Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Mycotic Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00794703
What this trial is testing

Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections

Who this might be right for
FungemiaFungal Infections
Astellas Pharma Inc 288
Early research (Phase 1)Study completedNCT01026636
What this trial is testing

A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age

Who this might be right for
Staphylococcal Skin InfectionsStreptococcal Infections
Basilea Pharmaceutica 64
Post-approval studies (Phase 4)WithdrawnNCT05355350
What this trial is testing

PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections

Who this might be right for
Beta Lactam Resistant Bacterial InfectionEnterobacteriaceae InfectionsBacteremia
Rambam Health Care Campus
Post-approval studies (Phase 4)Study completedNCT00417235
What this trial is testing

Dressing: Frequency of Change and Evaluation of an Antiseptic-Impregnated Catheter Dressing in ICU Patients

Who this might be right for
Systemic Inflammatory Response SyndromeBacteremia
University Hospital, Grenoble 1,600
Early research (Phase 1)Study completedNCT01134341
What this trial is testing

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T-cell LymphomaMycosis FungoidesSezary Syndrome+1 more
Acrotech Biopharma Inc. 34
Early research (Phase 1)Study completedNCT00004002
What this trial is testing

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
NYU Langone Health
Not applicableStudy completedNCT01867905
What this trial is testing

Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock

Who this might be right for
Severe SepsisSeptic ShockBacteremia
University of British Columbia 330
Large-scale testing (Phase 3)Study completedNCT02168946
What this trial is testing

Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults

Who this might be right for
Urinary Tract Infection ComplicatedAcute PyelonephritisHospital Acquired Bacterial Pneumonia+3 more
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 77
Not applicableStudy completedNCT03153384
What this trial is testing

Impact of the Blood Culture Technique on the Diagnosis of Infective Endocarditis

Who this might be right for
BacteremiaInfective Endocarditis
Central Hospital, Nancy, France 269
Not applicableEnrolling By InvitationNCT07107555
What this trial is testing

Necrotizing Soft Tissue Infections

Who this might be right for
Necrotizing Soft Tissue InfectionFournier GangreneSepsis+2 more
European Society for Trauma and Emergency Surgery 480
Early research (Phase 1)Study completedNCT00001515
What this trial is testing

Diagnostic Effectiveness of Virtual Bronchoscopy

Who this might be right for
Bronchogenic CarcinomaChronic Granulomatous DiseaseJob's Syndrome+2 more
National Institutes of Health Clinical Center (CC) 120
Not applicableStudy completedNCT03356249
What this trial is testing

Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis

Who this might be right for
SepsisSeptic Shock
University Hospital Heidelberg 500
Not applicableStudy completedNCT00177736
What this trial is testing

Pharmacodynamic Parameters of Two Different Doses of Cefepime

Who this might be right for
InfectionBacteremiaPneumonia
University of Pittsburgh 180
Testing effectiveness (Phase 2)Study completedNCT00002192
What this trial is testing

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.

Who this might be right for
Mycobacterium Avium-Intracellulare InfectionHIV Infections
Anderson Clinical Research
Not applicableStudy completedNCT03306784
What this trial is testing

Pain Catastrophizing and Routine Assessment of Patient Index Data 3(RAPID3) in Ten Categories of Rheumatology Outpatients

Who this might be right for
Arthritis, RheumatoidSpondyloarthritisInflammatory Rheumatisms+1 more
Nantes University Hospital 572
Not applicableLooking for participantsNCT06821282
What this trial is testing

Surveillance of AMR in DRC

Who this might be right for
Bacteremia
University of Oxford 210
Early research (Phase 1)Study completedNCT00734890
What this trial is testing

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+2 more
National Institutes of Health Clinical Center (CC) 18
Large-scale testing (Phase 3)Study completedNCT01792804
What this trial is testing

Staphylococcus Aureus Bacteremia Antibiotic Treatment Options

Who this might be right for
Staphylococcus Aureus Infection
Heinrich-Heine University, Duesseldorf 215
Not applicableStudy completedNCT01413555
What this trial is testing

Multicenter Blood Culture Quality Improvement

Who this might be right for
Bacteremia
Vanderbilt University 14,889
Large-scale testing (Phase 3)Study completedNCT03363841
What this trial is testing

Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)

Who this might be right for
Candidiasis, InvasiveCandidemia
Scynexis, Inc. 30
Next Page